Related Experiment Video

Updated: Aug 21, 2026

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates
09:47

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates

Published on: May 10, 2022

N-Terminal polyubiquitination of the ARF tumor suppressor, a natural lysine-less protein

Mei-Ling Kuo1, Willem den Besten, Charles J Sherr

  • 1Howard Hughes Medical Institute, Department of Genetics and Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.

Cell Cycle (Georgetown, Tex.)
|October 7, 2004
PubMed

Insights

N-terminal polyubiquitination targets proteins for proteasomal degradation. This mechanism regulates the turnover of the human ARF tumor suppressor, even in lysine-deficient forms, revealing a novel cellular protein degradation pathway.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Biochemistry

Background:

  • Proteasome-mediated protein degradation typically requires polyubiquitination at lysine residues.
  • Engineered proteins lacking lysine residues can be polyubiquitinated at their N-termini.
  • The physiological relevance of N-terminal polyubiquitination remains largely unexplored.

Purpose of the Study:

  • To investigate whether N-terminal polyubiquitination is a physiological process.
  • To determine the extent to which cellular proteins are targeted for proteasomal degradation via N-terminal polyubiquitination.
  • To examine the role of N-terminal polyubiquitination in the turnover of the human ARF tumor suppressor protein.

Main Methods:

  • Analysis of protein turnover mechanisms.
  • Investigation of ubiquitination pathways.
  • Study of engineered lysine-less protein mutants.
  • Examination of endogenous tumor suppressor protein regulation.

Main Results:

  • N-terminal polyubiquitination can target proteins for proteasomal degradation.
  • The endogenous lysine-deficient human ARF tumor suppressor protein undergoes N-terminal polyubiquitination.
  • The mouse Arf protein, with a single non-conserved lysine, is also regulated by this mechanism.

Conclusions:

  • N-terminal polyubiquitination represents a physiological mechanism for protein degradation.
  • This pathway plays a role in regulating the turnover of critical cellular proteins like ARF.
  • The findings expand our understanding of ubiquitin-dependent proteolysis and its regulatory scope.

More Related Videos

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model09:00

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model

Published on: April 17, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...